Literature DB >> 9741540

Expression of cyclin dependent kinase inhibitor p21WAF1 alone and in combination with p27KIP1 shows prognostic value in gastric carcinoma.

S J Jang1, M J Ahn, S S Paik, G Kong, J S Keum, Y W Park, J D Lee.   

Abstract

Evidence suggests that multiple molecular events, including alteration of cell cycle regulators are involved in the development and progression of gastric carcinoma. Recently, it has been reported that the expression of p21 and p27, integrating the effects of one or more cell cycle regulators, consequently, acting as a single indicator of several possible cell cycle gene alterations is associated with tumor suppression. In the present study, we studied the immunohistochemical expression of p21 and p27 in gastrectomy specimens from 84 patients with gastric adenocarcinoma, and analysed its correlation to clinicopathologic data, including patients survival. Loss of p21 and p27 expression was noted in 45 (53.6%) and 44 (52.4%) of the 84 gastric carcinoma tissues, respectively. The expression of p21 was significantly correlated with histological type (p= 0.005), recurrence (p=0.002) and death (p=0.002) after surgery, and p27 expression (p=0.001). Kaplan-Meier survival plots showed p21 negative group (p= 0.0014) or both p21 and p27 negative group (p=0.0048) was significantly poorer in overall survival than both p21 and p27 positive or one of both positive group. Our results suggest that the status of p21 and p27 expression in immunohistochemical stain may be a useful prognostic marker of gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9741540      PMCID: PMC3054414          DOI: 10.3346/jkms.1998.13.4.369

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  5 in total

1.  Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinoma.

Authors:  Roberson A Moron; Carlos Eduardo Jacob; Claudio José Caldas Bresciani; Kleber Simões; Venâncio Avancini Ferreira Alves; Kyoshi Irya; Joaquim Gama-Rodrigues; Ivan Cecconello; Adhemar Longatto-Filho; Bruno Zilberstein
Journal:  Mol Clin Oncol       Date:  2017-12-29

2.  Targeting molecular pathways with camptothecin as novel therapy for gastric cancer.

Authors:  D A Litvak; H T Papaconstantinou; B M Evers; C M Townsend
Journal:  J Gastrointest Surg       Date:  1999 Nov-Dec       Impact factor: 3.452

3.  Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer.

Authors:  Armando Gamboa-Dominguez; Stefan Seidl; Edgardo Reyes-Gutierrez; Christine Hermannstädter; Leticia Quintanilla-Martinez; Raymonde Busch; Heinz Höfler; Falko Fend; Birgit Luber
Journal:  J Clin Pathol       Date:  2007-05-04       Impact factor: 3.411

4.  Prognostic significance of p21 and p53 expression in gastric cancer.

Authors:  Young-Ho Seo; Young-Eun Joo; Sung-Kyu Choi; Jong-Sun Rew; Chang-Soo Park; Sei-Jong Kim
Journal:  Korean J Intern Med       Date:  2003-06       Impact factor: 2.884

5.  Clinical significances of p27 in digestive tract cancers: a comprehensive analysis on immunohistochemistry staining, published literatures, microarray and RNA-seq data.

Authors:  Dan-Dan Xiong; Rong-Quan He; Ai-Hua Lan; Wen-Jie Chen; Yi-Huan Luo; Zhi-Hua Ye; Jie Ma; Gang Chen; Yi-Wu Dang
Journal:  Oncotarget       Date:  2018-01-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.